SW-033291

N/A

Report date: 2025/03/07 11:54:14
NME

Base Information

Drug NameSW-033291
Drug Alias NameSW-033291SW033291
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action15-hydroxyprostaglandin dehydrogenase [NAD(+)] inhibitors
Targets15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Therapy Area/IndicationsColitis, UlcerativeColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesCase Western Reserve UniversityRodeo Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsColitis, UlcerativeColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A